Summary
Definição
História e exame físico
Principais fatores diagnósticos
- digoxin exposure
- gastrointestinal symptoms
- central nervous system symptoms
- visual symptoms
Outros fatores diagnósticos
- suicidality
- cardiovascular symptoms
Fatores de risco
- age >70 years
- decreased renal clearance
- hypokalemia (<3.0 to 3.5 mEq/L)
- concomitant use of specific drugs
- hypomagnesemia
- hypercalcemia
- hypothyroidism
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- ECG
- digoxin serum concentration
- serum potassium level
- serum magnesium level
- serum creatinine and BUN
Algoritmo de tratamento
acute ingestion, low to moderate toxicity
chronic ingestion, low to moderate toxicity
severe toxicity or hemodynamic compromise (acute or chronic toxicity)
acute or chronic toxicity after initial treatment
Colaboradores
Consultores especialistas
Scott Phillips, MD
Associate Clinical Professor of Medicine
Department of Medicine
University of Colorado
Denver
CO
Clinical Assistant Professor
Department of Pharmacy
University of Washington
Seattle
WA
Chief Executive Officer/Medical Director
Washington Poison Center
Seattle
WA
Declarações
SP declares that he has no competing interests.
Acknowledgements
BMJ Best Practice would like to gratefully acknowledge Dr Silas Smith for his advice on content in this topic.
Silas Smith MD, FACEP, FACMT
JoAnn G. and Kenneth Wellner Clinical Associate Professor of Emergency Medicine
NYU Langone
Ronald O. Perelman Department of Emergency Medicine
New York
NY
Declarações
SS's academic medicine organization has received U.S. federal research grants.
Agradecimentos
Dr Scott Phillips would like to gratefully acknowledge Dr Oladapo A. Odujube and Dr Robert S. Hoffman, previous contributors to this topic.
Declarações
OAO and RSH declare that they have no competing interests.
Revisores
Edward W. Boyer, MD
University of Massachusetts Medical School
Worcester
MA
Declarações
EWB declares that he has no competing interests.
Ruben Thanacoody, MD, FRCP(Edin)
Consultant Physician and Clinical Toxicologist
National Poisons Information Service (Newcastle)
Newcastle-upon-Tyne
UK
Declarações
RT declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Referências
Principais artigos
Andrews P, Anseeuw K, Kotecha D, et al. Diagnosis and practical management of digoxin toxicity: a narrative review and consensus. Eur J Emerg Med. 2023 Dec 1;30(6):395-401.Texto completo Resumo
Hack JB, Wingate S, Zolty R, et al. Expert consensus on the diagnosis and management of digoxin toxicity. Am J Med. 2025 Jan;138(1):25-33.e14.Texto completo Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
Diagnósticos diferenciais
- Beta-blocker toxicity
- Calcium-channel blocker toxicity
- Clonidine toxicity
Mais Diagnósticos diferenciaisDiretrizes
- 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay
- Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning
Mais DiretrizesFolhetos informativos para os pacientes
Heart attack
Heart failure
Mais Folhetos informativos para os pacientesConectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal